Washington, United States,
08048034981
Lirafit Injection | Product Information & Availability | City Drug House
Explore Lirafit Injection at City Drug House. View product information, prescription requirements and international availability for USA, Washington, New Zealand, Zimbabwe & Philippines.

Lirafit injection (liraglutide) is a prescription GLP-1 receptor agonist medication used alongside diet and exercise to help control blood sugar levels in adults with type 2 diabetes.

What is Lirafit Injection and how does it work?
Lirafit contains liraglutide, which mimics the natural hormone GLP-1.
It stimulates insulin release, reduces glucose production in the liver, and slows stomach emptying to keep blood sugar in a healthy range.

How is Lirafit injected?
Frequency: It is injected under the skin (subcutaneously) once a day at any time, preferably at the same time each day.

Sites: Common injection sites include the stomach (abdomen), thigh, or upper arm.
Missed dose: If you forget a dose, inject it as soon as you remember, then continue with your normal daily schedule.

What are the common side effects?
Mild nausea, vomiting, or diarrhea
Decreased appetite or constipation
Headache and tiredness
Redness, pain, or itching at the injection site

Who should avoid Lirafit?
Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Women who are pregnant, planning a pregnancy, or breastfeeding.
Patients with Type 1 diabetes or diabetic ketoacidosis (it is not a substitute for insulin in Type 1 diabetes).

City Drug House Exporters provides:

Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :

📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 7666132978
Aug 27th, 2026 3:12 PM

Keywords